Share on Pinterest Semaglutide may be effective in treating a form of fatty liver disease, new research shows. Steve Christo – Corbis/Getty Images Semaglutide is a GLP-1 agonist medication that ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

Apr. 30, 2025 — Semaglutide effectively treats liver disease in two thirds of patients, new research has ... New Human 'Multi-Zonal' Liver Organoids Improve Injury Survival in Rodents Apr. 16 ...

In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in ...

Improves fibrosis and steatohepatitis Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad clinical spectrum, ranging from simple steatosis to metabolic ...

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...